Genitope Corp

A. Company Profile

Genitope (NASDAQ:GTOP) is a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer.

B. Products

1. MyVax Personalized Immunotherapy

MyVax Personalized Immunotherapy, GTOP-99, is a treatment based on the unique genetic makeup of a patient's tumor and is designed to activate a patient's immune system to identify and attack cancer cells. As such, MyVax Personalized Immunotherapy is commonly referred to as a patient-specific or personalized immunotherapy, an active idiotype immunotherapy, or a patient-specific or personalized cancer vaccine. This type of immunotherapy is intended to stimulate an active and durable immune response specifically against an individual patient's malignant cells. Each therapy is also tumor-specific, so that in theory, cells other than those of the tumor should not be affected.